Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Review
Nature Reviews Cancer 5, 965–976 (1 December 2005) | doi:10.1038/nrc1750
Recent progress in the battle between oncolytic viruses and tumours
&
Abstract
In the past 5 years, the field of oncolytic virus research has matured significantly and is moving past the stage of being a laboratory novelty into a new era of preclinical and clinical trials. What have recent anticancer trials of oncolytic viruses taught us about this exciting new line of therapeutics?
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
